We serve Chemical Name:4-bromo-4,4-difluorobutanoic acid CAS:147345-36-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:4-bromo-4,4-difluorobutanoic acid
CAS.NO:147345-36-6
Synonyms:Butanoic acid,4-bromo-4,4-difluoro;4-Bromo-4,4-difluorobutyric acid;PC1386P
Molecular Formula:C4H5BrF2O2
Molecular Weight:202.98200
HS Code:2915900090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:217.2ºC at 760mmHg
Density:1.791g/cm3
Index of Refraction:1.445
PSA:37.30000
Exact Mass:201.94400
LogP:1.83890
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like Butanoic acid,4-bromo-4,4-difluoro chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,PC1386P physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-Bromo-4,4-difluorobutyric acid Use and application,4-Bromo-4,4-difluorobutyric acid technical grade,usp/ep/jp grade.
Related News: It’s a disturbing set of events, scientifically, clinically, politically, Karlawish said. 4-bromo-4,4-difluorobutanoic acid manufacturer The FDA issued a stark warning to the public urging them to stop using rapid COVID-19 antigen tests developed by Innova Medical Group, the company previously tapped by the U.K. government for hundreds of millions of kits to help regularly screen the country’s population. 4-bromo-4,4-difluorobutanoic acid supplier He was the partner of a 38-year-old Chinese woman who was travelling with him. She was the first confirmed case reported in the Philippines. 4-bromo-4,4-difluorobutanoic acid vendor Fate Therapeutics has exclusively licensed from MSK foundational intellectual property covering the production and composition of iPSC-derived T cells. 4-bromo-4,4-difluorobutanoic acid factory The FDA issued a stark warning to the public urging them to stop using rapid COVID-19 antigen tests developed by Innova Medical Group, the company previously tapped by the U.K. government for hundreds of millions of kits to help regularly screen the country’s population.
